|
Market Closed -
Nasdaq
16:00:00 2026-10-21 EDT
|
5-day change | 1st Jan Change | ||
| 11.18 USD | -1.93% |
|
+1.18% | -45.09% |
| 09-29 | Keros Therapeutics Expects $20 Million Milestone Payment From Takeda | MT |
| 09-29 | Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda | CI |
Stock exchange
Quotes 5-day view: Keros Therapeutics, Inc.
Delayed Quote Nasdaq
| 2026-10-15 | 2026-10-16 | 2026-10-19 | 2026-10-20 | 2026-10-21 | |
|---|---|---|---|---|---|
| Last | US$11.10 | US$10.66 | US$11.06 | US$11.40 | US$11.18 |
| Volume | 96,665 | 169,639 | 210,647 | 153,379 | 178,140 |
| Change | +0.45% | -3.96% | +3.75% | +3.07% | -1.93% |
| Opening | US$11.13 | US$11.11 | US$10.68 | US$11.04 | US$11.40 |
| High | US$11.40 | US$11.13 | US$11.15 | US$11.67 | US$11.68 |
| Low | US$10.98 | US$10.63 | US$10.66 | US$11.04 | US$11.11 |
Performance
| 1 day | -1.93% | ||
| 1 week | +1.18% | ||
| Current month | -1.93% | ||
| 1 month | -2.61% | ||
| 3 months | +5.77% | ||
| 6 months | -1.15% | ||
| Current year | -45.09% | ||
| 1 year | -27.45% | ||
| 3 years | -60.55% | ||
| 5 years | -70.77% |
Volumes
marketsDaily volume
178,141
Estimated daily volume
178,141
Avg. Volume 20 sessions
174,274
Daily volume ratio
1.02
Avg. Volume 20 sessions USD
1,948,383.32
Record volume 1
14,645,678
Record volume 2
13,601,225
Record volume 3
5,812,484
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
226,029,943
Net sales (USD)
244,061,000
Number of employees
92
Sales / Employee (USD)
2,652,837
Free-Float
46.49%
Free-Float capitalization (USD)
217,070,820
Average Daily Capital Traded
0.86%
Indicators
Moving average 5 days
11.08
Moving average 20 days
11.34
Moving average 50 days
11.18
Moving average 100 days
10.9
Price spread / (MMA5)
-0.89%
Price spread / (MMA20)
+1.40%
Price spread / (MMA50)
-0.04%
Price spread / (MMA100)
-2.53%
STIM
RSI 9 days
53.21
RSI 14 days
52.2
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.93% | +1.18% | -27.45% | -60.55% | 226M | |
| -0.21% | -4.43% | +44.40% | +74.13% | 66.34B | |
| +0.82% | +5.41% | +8.05% | +73.53% | 54.82B | |
| -0.22% | +6.53% | +11.68% | +87.32% | 52.92B | |
| +3.28% | +5.58% | +26.51% | +50.05% | 44.09B | |
| +0.51% | +9.95% | +22.40% | +133.92% | 43.72B | |
| -1.15% | +0.39% | +263.21% | +594.60% | 42.13B | |
| +0.10% | +9.90% | +16.11% | +59.33% | 33.96B | |
| -2.15% | -0.29% | +35.40% | +5.09% | 26.17B | |
| +0.69% | +5.60% | +36.60% | +26.94% | 23.37B | |
| Average | +0.01% | +4.38% | +43.69% | +104.44% | 38.77B | |
| Weighted average by Cap. | +0.28% | +4.54% | +50.46% | +127.52% |
Historical Quotes: Keros Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
4e6aad6e7c89ab.7TlP0X5Ii_YBIR8ZhesLo6ws4BD7njLJ1GsxSRQdUL8.i0wcqCcs_JM3a0Vf_4RG5uMBjmSV8mGOgFJ7fn50F--nZiqHBi3olXgWXg
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 11.18 | 20,850 | 119,862 |
| 15:59:51 | 11.18 | 100 | 99,012 |
| 15:59:51 | 11.18 | 100 | 98,912 |
| 15:59:24 | 11.16 | 100 | 98,812 |
| 15:59:24 | 11.17 | 144 | 98,712 |
| 15:59:24 | 11.17 | 104 | 98,568 |
| 15:59:24 | 11.17 | 102 | 98,464 |
| 15:59:24 | 11.16 | 100 | 98,362 |
| 15:59:24 | 11.17 | 300 | 98,262 |
| 15:59:24 | 11.17 | 748 | 97,962 |
Price Extremes
| 1 week | 10.63 |  | 11.68 |
| 1 month | 10.63 | | 12.26 |
| Current year | 9.69 | | 20.34 |
| 1 year | 9.69 | | 22.55 |
| 3 years | 9.12 | | 73 |
| 5 years | 9.12 | | 73 |
| 10 years | 9.12 | | 88.8 |
Monthly variations
Annual variations
| 2026 | -45.09% | ||
| 2025 | +28.62% | ||
| 2024 | -60.19% | ||
| 2023 | -17.20% | ||
| 2022 | -17.93% | ||
| 2021 | -17.05% | ||
| 2020 | +251.29% |
- Stock Market
- Stocks
- KROS Stock
- Quotes Keros Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
